Trauma BPE Prolonged Exposure Therapy for Injured Individuals Admitted to a Level I Trauma Center
Key facts
- Who runs it
- Baylor Research Institute
- Where
- Dallas, Milwaukee, and Temple, United StatesSee the 3 sites
- Trial code
- Status
- Recruiting
- People taking part
- 300 people, planned
- Started
- 28 Feb 2024
- Expected to end
- Sept 2027
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Treatment as Usual
- Brief Prolonged Exposure Therapy
- Record updated
- 15 October 2026
Who can take part
- Age
- 18 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Between the ages of 18 and 75 years old
- Admitted to Baylor University Medical Center at Dallas (BUMC), Baylor Scott \& White Medical Center at Temple (BSWMC), or Froedtert Hospital and the Medical College of Wisconsin (FH/MCW) Level 1 Trauma Center
Who cannot take part
- Patients with severe cognitive impairment
- Patients in police custody
- Patients not fluent in English
- Patients who are acutely suicidal
- Patients with active psychosis
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 75 years old?
Where in United States
- Baylor University Medical CenterDallas, United StatesContact: Roxane GonodTaking people
- Froedtert & Medical College of WisconsinMilwaukee, United StatesContact: Kelley Jazinski-ChambersTaking people
- Baylor Scott & White Medical Center - TempleTemple, United StatesContact: Valerie Danesh, PhDTaking people
About the trial
What the trial wants to find out
The purpose of this research is to determine if a brief treatment method is effective for preventing posttraumatic stress disorder (PTSD) and a number of other concerns following injury.
The 2 groups in the trial
- Treatment as UsualPlacebo, for comparison
Participants in the Treatment as Usual group (TAU) will not receive the Brief PE therapy, but the standard clinical treatment received by all patients admitted to BUMC, BSWMC Temple or FH/MCW trauma centers. Treatment as usual participants will have follow-up assessments at 1, 3, and 6 months from Baseline.
- Brief Prolonged ExposureTreatment being tested
Participants in the experimental group will receive Brief Prolonged Exposure Therapy. In addition to the standard clinical treatment received by all patients at BUMC, BSWMC Temple and FH/MCW (treatment as usual), participants randomized to the intervention condition will also receive three 60-minute sessions of Brief PE. Participants in the BPE group will complete a screener and then questionnaires/interviews at 1, 2, and 6 months from Baseline.
Treatment: Brief Prolonged Exposure Therapy
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Prevention of Posttraumatic Stress: A Randomized Controlled Trial of Brief Prolonged Exposure Therapy for Injured Individuals Admitted to a Level I Trauma Center
- Fit questions
- Built from NCT06210711, who can take part
- Record updated
- 15 October 2026